Navigation Links
Haemacure Reports on its annual general and special meeting of shareholders
Date:4/9/2008

HAE:TSX

MONTREAL, April 9 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, reports on its Annual General and Special Meeting of Shareholders held this afternoon.

Results of Preclinical Study of Fibrin Sealant in Adhesion Prevention

Haemacure presented the positive results of a preclinical study it recently conducted on the use of the current formulation of its proprietary lead product candidate, the human fibrin sealant Hemaseel(R)HMN. Haemacure's fibrin sealant proved superior to the untreated control subjects in open surgery in preventing the formation of post-surgical adhesions. It also proved to be superior to the data found in published literature for GYNECARE INTERCEED(TM) (TC7) Absorbable Adhesion Barrier, marketed by Ethicon, Inc. Haemacure plans on expanding the fields of use for its fibrin sealant by entering the adhesion prevention market, thanks to the leveraging of the current formulation of its fibrin sealant. Post-surgical adhesions are estimated to cost the U.S. healthcare system US$2.1 billion annually.

New Manufacturing Facility on Schedule and on Budget

Haemacure reported that the construction of its small scale manufacturing facility in Sarasota, Florida is progressing on schedule and on budget. The targeted completion date is mid-2008, as planned. The construction of a small-scale facility is the first phase of Haemacure's two-phase strategy to significantly reduce the cost of meeting its First-Patient-In objective during the first quarter of 2009. The second phase of the strategy consists in expanding the facility during the review of its license applications by regulatory authorities, and in completing the development of Haemacure's second product candidate, the Hemaseel(R)Thrombin active hemostatic agent. Haemacure's fibrin seal
'/>"/>

SOURCE Haemacure Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
11. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013) Aortic arch pulse wave velocity, a ... of disease of the vessels that supply blood to ... the June issue the journal Radiology . ... functional information about vessel compliance that may help determine ... said Kevin S. King, M.D., assistant professor of radiology ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Applied PilotFish ... announced today that it has added support for the ... IDE, the eiConsole for Healthcare. In addition to the ... as LLP, FTP, and Web Services, it now offers ... Direct Protocol is a specification of the Direct ...
(Date:5/23/2013)... Elegance for a woman takes on so many ... her intrigue can often be found in the mystery of her ... soul is through her eyes. It is also true that ... is why the elegance of a woman can be found in ... more than any other time, utilize eyewear to not only compliment ...
(Date:5/23/2013)... Aero Fulfillment Services, a national provider of ... to be the sole fulfillment provider for Olivenol® plus ... Brad Cole, CEO New Wave Biosciences said, “We chose ... location, e-commerce experience with both of our key audiences ... that will expand as our distribution grows.” He ...
(Date:5/23/2013)... Each month Dwell magazine is filled with ... electric cars. Nowhere in America are these pages more scoured ... capital. Thankfully this June, Green Car Journal is bringing its ... Dwell on Design 2013 ( http://www.dwellondesign.com ), America’s ... days of Dwell on Design, June 21-22, attendees and media ...
Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5
... the lymph nodes also, according to a recent research, led ... immune response. // ,The dreaded disease is ... and the immature parasites travel to the animal's liver. Once ... liver cells and infect red blood cells, beginning the onset ...
... the teenaged girls in the UK are virtually starving themselves to ... Agency and Sugar magazine. // Some of these girls are reported ... 50 per cent always skip breakfast and do not know what ... they eat ‘as little as possible,’ while ten per cent said ...
... risk factors like blood pressure, age and medical history. Those who ... can be treated as outpatients, according to a publication in ... abrupt blockage of an artery due to a blood clot, or ... major health hazard. This is not fatal in the case of ...
... many as 20% of the men in the US suffer ... other diseases, including heart diseases. // The number of visits ... was introduced in 1998. The data available from the National ... S. Saigal and his colleagues. ,About 2,126 men ...
... that as many as 250,000 Scots are unable to access ... Health Department had drawn up an emergency care plan which ... as ?1.5 million has been allocated for this. The situation ... 10% of the population having to wait for a period ...
... a survey in 5 European countries on how women lead ... to find out whether women enjoyed the present life ... the work was funded by Economic and Social Research Council. ... have problems with their family life. ,Researchers found ...
Cached Medicine News:Health News:Malaria Can Develop In Lymph Nodes Also 2
(Date:5/23/2013)... 2013  Echo Pharma Acquisition Limited ("Royalty Pharma") announced ... Acceptance Threshold from 90 percent to 50 percent of ... accordance with the terms of the Revised Offer Document ... Under the terms of the Increased Offer, Royalty ... ELN ) for $12.50 per share in cash. The ...
(Date:5/23/2013)... 2013 Nederland keurt als eerste ... geassocieerd met BPH Astellas Pharma ... Pharma Inc, gebaseerd in Tokyo ... dat het Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) ... De handelsvergunning verleend voor VESOMNI is voor "de ...
(Date:5/22/2013)... LAGUNA HILLS, Calif. , May 22, 2013 /PRNewswire/ ... is developing a medical device that will help alleviate ... preeclampsia. APT,s targeted apheresis cartridge is expected to be ... a leading cause of maternal and fetal death. ... in the United States . It ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... YORK, Sept. 16 Reportlinker.com announces that ... in its catalogue: Prosthetic ... Assessment and Market Forecasts to 2016 ... Prosthetic Heart Valves - Global Pipeline Analysis, ...
... MedClean Technologies (OTC Bulletin Board: MCLN ), ... and disposal of medical waste and the destruction of ... signed a distribution agreement with Trojan Energy Systems, Inc., ... years of combined experience in the sale and service ...
Cached Medicine Technology:Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 2MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: